TipRanks
Go Ultimate55% OFF

Oriental Aromatics Ltd. (OAL) AI Stock Analysis

Top Page

IN:OAL

Oriental Aromatics Ltd.

(NSE:OAL)

Select Model
Rating:51Neutral
Price Target:INR 631.00â–²(10.08% Upside)
Action:reiterated
Date:10/17/26

The score is held back primarily by weak financial quality—sharp margin compression, volatile earnings, recurring negative operating/free cash flow, and higher leverage. Technicals are a positive (strong uptrend and bullish momentum), but the stock appears stretched (high RSI). Valuation is a key risk: an extremely high P/E contrasts with pressured profitability, partially offset by a high dividend yield.

Positive Factors
Revenue GrowthTop-line growth indicates that OAL is expanding sales across its aroma and specialty chemical activities. Continued revenue expansion can support operating scale, strengthen customer reach, and provide a foundation for recovery if profitability and cash conversion improve.
Negative Factors
Severe Margin CompressionThe sharp deterioration in gross and net margins shows that revenue growth is currently producing very little profit. Persistently thin margins reduce resilience against cost or pricing pressure, constrain reinvestment, and make earnings recovery dependent on restoring profitability.

Oriental Aromatics Ltd. (OAL) vs. iShares MSCI India ETF (INDA)

-50%-25%0%25%50%75%100%IN:OAL+68.74%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 19.16B
Dividend Yield
0.09%
Average Volume (3M)
6,841
Price to Earnings (P/E)
360.3
Beta (1Y)
1.15
Revenue Growth
13.55%
EPS Growth
-77.69%
Country
India
Employees
735
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Oriental Aromatics Ltd. Business Overview & Revenue Model

Company Description

Oriental Aromatics Limited, established in Mumbai, India, in 1955, is a leading manufacturer and supplier of terpene chemicals, camphor, and various specialty aroma ingredients. Operating as Camphor & Allied Products Limited until its rebranding in F...

How the Company Makes Money

OAL makes money primarily by manufacturing and selling aroma and specialty chemical products to business customers (B2B). Its core revenue stream is product sales: customers (such as fragrance houses, flavor and fragrance ingredient blenders, and for...

Oriental Aromatics Ltd. Financial Statement Overview

Summary

Revenue is rising, but profitability has deteriorated sharply: gross margin compressed materially and net margin is now extremely thin (≈0.3% in 2026). Cash generation is the major concern with operating cash flow and free cash flow negative in most years and worsening in 2026, while leverage has increased meaningfully—together signaling elevated funding and execution risk.

Income Statement

38Negative

Balance Sheet

62Positive

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue10.65B10.31B9.23B8.36B8.49B8.66B
Gross Profit1.03B1.02B1.30B1.52B1.62B1.89B
EBITDA727.41M775.92M966.65M534.64M543.09M969.36M
Net Income53.20M33.10M343.28M91.04M197.43M533.02M
Balance Sheet
Total Assets011.94B11.45B9.95B9.86B8.65B
Cash, Cash Equivalents and Short-Term Investments131.28M146.14M111.85M111.76M181.12M77.28M
Total Debt04.03B3.53B2.06B2.31B1.40B
Total Liabilities-6.65B5.30B4.82B3.63B3.62B2.60B
Stockholders Equity6.65B6.65B6.63B6.32B6.25B6.05B
Cash Flow
Free Cash Flow-342.96M-441.80M-1.45B424.36M-689.99M-603.09M
Operating Cash Flow-304.21M-323.99M-578.94M1.42B-223.00M-8.14M
Investing Cash Flow-38.75M-116.43M-865.04M-989.66M-464.66M-594.42M
Financing Cash Flow258.42M465.75M1.44B-482.00M781.48M514.81M

Oriental Aromatics Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price573.20

Price Trends

50DMA516.34Positive
100DMA432.52Positive
200DMA357.90Positive

Market Momentum

MACD27.08Positive
RSI52.43Neutral
STOCH59.81Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OAL, the sentiment is Positive. The current price of 573.20 is above the 20-day moving average (MA) of 566.14, above the 50-day MA of 516.34, and above the 200-day MA of 357.90, indicating a bullish trend. The MACD of 27.08 indicates Positive momentum. The RSI at 52.43 is Neutral, neither overbought nor oversold. The STOCH value of 59.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:OAL.

Oriental Aromatics Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:OAL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:FINEORGIN:FINEORG75OutperformINR 154.84B35.84―0.22%7.26%5.73%
IN:GALAXYSURFIN:GALAXYSURF59NeutralINR 75.16B21.20―1.04%27.05%16.13%
IN:BALAMINESIN:BALAMINES58NeutralINR 57.16B27.90―0.63%11.08%34.10%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:OALIN:OAL51NeutralINR 19.29B360.32―0.09%13.55%-77.69%
IN:LXCHEMIN:LXCHEM50NeutralINR 42.47B33.72―0.20%5.47%24.88%
IN:CAMLINFINEIN:CAMLINFINE30UnderperformINR 16.15B323.46――8.40%―

* General Sector Average

Performance Comparison

-50%0%50%IN:OALIN:BALAMINESIN:CAMLINFINEIN:FINEORGIN:GALAXYSURFIN:LXCHEMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:OAL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:OALOriental Aromatics Ltd.573.20226.9565.55%
IN:BALAMINESBalaji Amines Limited1764.15351.1024.85%
IN:CAMLINFINECamlin Fine Sciences Limited84.05-115.70-57.92%
IN:FINEORGFine Organic Industries Ltd.5050.20641.2114.54%
IN:GALAXYSURFGalaxy Surfactants Ltd.2119.80-117.93-5.27%
IN:LXCHEMLaxmi Organic Industries Ltd.152.80-43.86-22.30%

Oriental Aromatics Ltd. Corporate Events

Oriental Aromatics Publishes AGM Notice in Line with SEBI Norms

Jul 25, 2026

Oriental Aromatics Limited notified stock exchanges that it has published newspaper advertisements regarding its 54th Annual General Meeting in leading English and Marathi dailies. The disclosure was made in line with SEBI Listing Regulations, unders...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 17, 2026